trial

A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses

NCTId NCT04612777
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 240 (actual)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2019-12-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
240 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2014-06-15
Primary completion
2019-12-05
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Opening Doors to RecoveryCase ManagementIntensive Case Management

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
Emory UniversityCollaborator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
240
Phase
NA
Primary Completion Date
2019-12-05
Status
COMPLETED
relationships
The graph out of here
drug
Opening Doors to Recovery
drug
Case Management
drug
Intensive Case Management
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
Emory University
company
indication
Bipolar Disorder
indication
Depressive Disorder
indication
Mental Disorders, Severe
indication